Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Deadline
49 days remaining
Non-Final Action Mailed
Due Date
September 22, 2025
Extension Available
Until December 22, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
8 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 22, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jun 22, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 22, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 21, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 21, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Dec 9, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Dec 9, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias
Additional Information
Design Mark
The mark consists of four purple check mark designs joined at their bottoms, forming a stylized starburst shape with two triangles in the center. The color white represents background, outlining, shading and/or transparent area and is not part of the mark.
Color Claim
The color(s) purple is/are claimed as a feature of the mark.
Classification
International Classes
005